跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Designs a Drug Molecule from Scratch

1Why Designing a Drug Molecule Is Hard2Turning Molecules into Something a Machine Can Read3How Generative Models Propose New Molecules4Scoring and Filtering the Candidates5Testing, Learning, and Improving the Design
Scoring and Filtering the Candidates

The Filters a Candidate Has to Pass

2 / 3
Follow the funnel from the wide top to the narrow bottom. The wide band is the candidate pool the generation stage produced. The first gate is drug-likeness: simple rules about size, greasiness, and polar groups that catch molecules unlikely to be absorbed. The next gate is safety, screening out reactive or toxic structural features. Then synthesizability, which asks whether a chemist could actually build the thing. Watch how much is removed at each stage. The point of the picture is that the shortlist at the bottom is not a set of winners — it is simply what survived several independent cuts, and each cut was made for a different reason.
0:00 / 0:00

Scoring produces a number for each candidate, but a number alone does not make a drug. A candidate also has to survive a set of filters that encode what medicinal chemists have learned about which molecules tend to work as medicines and which tend not to.

Drug-likeness filters are the most familiar. They are simple rules of thumb about size, how greasy the molecule is, and how many hydrogen-bonding groups it carries. The reasoning behind them is practical: a molecule that is too large or too greasy tends not to dissolve well enough to be absorbed, and one with too many polar groups tends not to cross membranes. These are tendencies, not laws, and many successful drugs break them — but they are cheap to apply and they remove a large fraction of hopeless candidates early.

Safety filters look for structural features that are known to cause trouble: groups that are chemically reactive, that are associated with toxicity, or that the body tends to convert into something harmful. Synthesizability asks a different question entirely — can a chemist actually make this molecule in a reasonable number of steps from available starting materials? A beautiful binder that would take twenty steps and exotic reagents to build is not a drug candidate; it is a curiosity.

The funnel is the right picture. Thousands of generated candidates enter, and each successive filter removes a large slice. What comes out the far end is a shortlist small enough for humans to examine and for a laboratory to test.

上一页2 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion